Delivery Order SPE2DB22D2218-SPE2DB25FR3AG
- Not listed
- The Defense Logistics Agency awarded a $44,543.69 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $34,386.90 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This firm fixed price, competitively awarded delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supply on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract, valued at $3,835.11 under a firm fixed-price arrangement, covers the delivery of Descovy 200-25 mg tablets in quantities of 30 units. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $3,023.88 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Descovy 200-25 mg Tablet. The contract has a firm fixed price and an ultimate completion date of October 21, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Descovy 200-25 mg tablets, a type of medication. The total ceiling value of the contract is $3,231.89, with a completion date of June 18, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,945.79 contract is for the delivery of Descovy 200-25 mg tablets. This order is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which provides global pharmaceutical support for military healthcare...
- The Defense Logistics Agency's Medical Supply Chain awarded a $47,021.50 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of DESCOVY 200-25 mg tablets (30-unit packs). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,012.81, is for the delivery of Descovy 200-25 mg tablets over the period ending on April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides a comprehensive global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,318.41 delivery order contract is for the provision of the prescription medication Descovy 200-25 mg tablet, with a performance period ending on May 9, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,666.33, is a firm fixed-price delivery order for the supply of the prescription medication Descovy 200-25 mg tablet. The contract has an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR3AGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $21,872.95. This competitively awarded, firm fixed-price delivery order is set to be completed by July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As the prime contractor under the comprehensive DLA pharmaceutical support vehicle, the company supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally. This delivery order for Descovy, an antiretroviral medication, exemplifies the company's role in fulfilling pharmaceutical supply requirements for the Defense Health Agency and other government healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.9k | 7/23/25 |